Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CRT > E4. Chronic HFREF Treatment > Flashcards

E4. Chronic HFREF Treatment Flashcards

1
Q

Left Sided HF

A

HFrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In the pathophysiology of HF, what component do beta-blockers address?

A

Catecholamine release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In the pathophysiology of HF, what component does RAAS inhibition and MRAs address?

A

The Juxtaglomerular Response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the Pathophysiology of HF, what component do MRAs, Nephrylisin inhibitors, and SLGT2is address?

A

Sodium and Water retention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In the pathophysiology of HF, what do beta-blocker and hydralazine act address?

A

Alpha-1 Stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What five drug classes are associated with mortality benefit in HF?

A
  1. Beta-blockers
  2. RAAS inhibitors
  3. Mineralocorticoid Receptor Antagonists
  4. SGLT2i
  5. Vaso/Venodilators
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What three beta-blockers are shown to have mortality benefits in HF?

A
  1. Carvedilol
  2. Metoprolol Succinate
  3. Bisoprolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which SGLT2i are shown to have morality benefit in HF?

A
  1. Dapagliflozin
  2. Empagliflozin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which vaso/venodilators are proven to have mortality benefit in HF?

A
  1. Hydralazine
  2. Isosorbide dinitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drugs are shown to have reduce morbidity only in HF?

A
  1. Ivabradine
  2. Vericiguat
  3. Digoxin
  4. Diurectics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which morbidity reducing drug should be used for patients on a max beta-blocker, who remain symptomatic with a heart rate above 70.

A

Ivabradine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which morbidity-reducing drug is a soluble guanylate cyclase stimulator?

A

Vericiguat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which morbidity reducing drug is a mild positive inotrope?

A

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T or F: Diurectics are shown to reduce morbidity in HF?

A

True.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In what situation should you add hydralazine-nitrates to a heart failure patient regimen?

A
  1. African American NYHA III-IV Heart Failure
  2. Patient can not tolerate RAAS inhibitors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Entresto Generic Name

A

Valsartan/Sacubitril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In Entresto, what is the mechanism of the sacubitril component?

A

It blocks the breakdown of brain natriuretic peptide. This leads to natriuresis and vasodilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the only contraindication to entresto? (Any RAAS inhibitor really)

A

Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

______ require a 36 hour wash out period prior to the initiation of entresto due the possibility of an acute bradykinin increase causing angioedema.

A

ACE-inhibitor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Entresto ADE (3)

A
  1. Hyperkalemia
  2. Acute Renal Failure (Bilateral renal artery stenosis)
  3. Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

At what potassium level should we not initiate entresto?

A

5.5 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

At what k+ level should we discontinue entresto?

A

5.6 mmol +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ACE-Inhibitor Contraindications

A
  1. History of angioedema
  2. Entresto use within 36 hours.
  3. Bilateral renal artery stenosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

RAAS inhibitors should not be initiated at a K+ level above _____.

A

5.0 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

RAAS inhibitors should be discontinued at a K+ level above _____.

A

5.6 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Rhabdomyolysis is a side effect of ____ (ACEi or ARB)

A

ARB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Entresto (Sacubitril/Valsartan) Target Dose

A

97/103 mg TWICE DAILY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Lisinopril Target Dose in HF

A

20-40 mg once daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Valsartan Target Dose in HF

A

160 mg Twice Daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

______ should be tapered upon discontinuation due to the risk for rebound tachycardia.

A

Beta-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

_____ may mask the symptoms of hypoglycemia in patients with diabetes.

A

Beta-Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

____ should be used with caution in patients with severe bronchospastic diseases.

A

Beta-blockers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Bisoprolol Brand Name

A

Zebeta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Bisoprolol Target Dose for HF

A

10 mg once daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Toprol XL generic name

A

Metoprolol succinate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Toprol XL target dose

A

200 mg Once daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Coreg Target Dose

A

25 mg twice daily

> 85 kg: 50 mg twice daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What beta-blocker must be adjusted for patients who weigh more than 85 kg?

A

Coreg (Carvedilol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the three contraindications for MRAs in HF?

A
  1. K+ (>5)
  2. Anuria
  3. CrCl <30 ml/min
40
Q

Which MRA is a CYP3A4 substrate?

A

Eplerenone

41
Q

Which MRA is associated with gynecomastia, breast tenderness, impotence.

A

Spironolactone

42
Q

Which MRA is associated with increased triglycerides?

A

Eplerenone.

43
Q

What are the ADEs of MRAs

A
  1. Dehydration
  2. Hyperkalemia
  3. Hyponatremia
  4. Dizziness
  5. Cardiac Arrythmias
44
Q

_______ have the following monitoring parameters:

Monitor Electrolytes and renal function at 2-3 days following initiation, and then 7 days after initiation/titration. Then, check monthly for 3 months, then every 3 months afterwards.

A

MRAs

45
Q

Spironolactone Target Dose in HF.

A

25-50 mg once daily.

46
Q

What does competitive antagonism at the mineralocorticoid receptor lead to?

A
  1. Decreased Sodium Reabsorption
  2. Increased Potassium Reabsorption.
47
Q

____ increases urine output by osmotic diuresis (glucose excretion). These are proposed to improve cardiac fibrosis.

A

SGLT2is

48
Q

Dapagliflozin is contraindicated below and eGFR of ______.

A

30 mL/min

49
Q

Empagliflozin is contraindicated below an EGFR of ____.

A

20 mL/Min

50
Q

This class is associated with Genetic Mycotic Infections, Hypoglycemia, and Euglycemic Ketoacidosis.

A

SGLT2i

51
Q

Dapagliflozin Target Dose

A

10 mg once daily.

52
Q

Empagliflozin Target Dose

A

10 mg once daily.

53
Q

This drug class, inhibits sodium, chloride, and potassium reabsorption in the thick ascending limb of the nephron.

A

Loop Diurectics.

54
Q

Loop Diurectic Contraindications.

A
  1. Anuria
  2. Hypersensitivity to Sulfa Drugs.
55
Q

Loop Diuretic Black Box Warning

A

Potent diuretic, at high doses may lead to profound fluid and electrolyte loss.

56
Q

This drug class is associated with:

~Hyponatremia, hypokalemia, hypomagnesesemia, hypocalcemia, hypochloremia.
~Metabolic Acidosis
~Hyperuricemia
~Orthostatic Hypotension
~Dizziness

A

Loop Diurectics

57
Q

This Drug class is associated with:
1. Acute Kidney Injury
2. Ototoxicity

A

Loop Diurectics

58
Q

Which loop diuretic should be considered if a patient has a true sulfa allergy?

A

Ethacrynic Acid.

59
Q

What conditions increase the loop diuretic threshold?

A
  1. Chronic Loop Diuretic Use
  2. AKI/CKD
  3. Heart Failure (Gut Edema)
60
Q

In heart failure, when should loop diuretics be added?

A

When they are experiencing signs of congestion (hypervolemia).

61
Q

What dose should be initiated in a loop diuretic naive patient with congestion?

A

20-40 mg Furosemide.

62
Q

What may need to be prescribed with a loop diuretic to maintain electrolyte balance?

A

Potassium

63
Q

What can be added to address resistance to loop diuretics?

A

Thiazide Diuretics.

64
Q

Resistance to _______ results due to reduced GFR, HF, and gut edema.

A

Loop Diuretic Resistance

65
Q

Furosemide Oral Starting Dose

A

40 mg

66
Q

Furosemide IV Starting Dose

A

20 mg

67
Q

Torsemide Oral Starting Dose

A

20 mg

68
Q

Torsemide IV Starting Dose

A

20 mg

69
Q

Bumetanide Oral Starting Dose

A

1 mg

70
Q

Bumetanide IV Starting Dose

A

1 mg

71
Q

Ethacrynic Acid Oral Starting Dose

A

50 mg

72
Q

Ethacrynic Acid IV Starting Dose

A

50 mg

73
Q

_______ is a vasodilator which is associated with Drug Induced Lupus Erythematosus.

A

Hydralazine.

74
Q

This vasodilator is contraindicated with recent PDE5 inhibitor or riociguat use.

A

Isosorbide Dinitrate.

75
Q

BiDil

A

20 mg isosorbide dinitrate/37.5 mg hydralazine.

76
Q

When is Ivabradine recommended for HFrEF?

A

NYHA II-III, with normal sinus rhythm but a HR above 70 bpm despite maximal beta-blocker use.

77
Q

When is Vericiguat recommended in HFrEF?

A

NYHA II-III with an LVEF < 45%, recent HF hospitalization, and elevated BNP.

78
Q

When is Digoxin recommended?

A

Symptomatic HF

79
Q

When are polyunsaturated fatty acids recommended in HF?

A

Occasionally to reduce HF hospitalizations.

80
Q

This drug inhibits the hyperpolarization of cyclic nucleotide-gated channels (f-channels) within the SA node of cardiac tissue. This leads to disruption of the funny channel leading to prolonged diastolic depolarization, slowing firing in the SA node and reducing HR.

A

Ivabradine

81
Q

Corlanor

A

Ivabradine

82
Q

Ivabradine CI

A
  1. Severe Hepatic Impairment
  2. ADHF
  3. Clinically Significant Hypotension
  4. Sick SInus Syndrome
  5. Sinoatrial Block
  6. Third Degree AV Block
83
Q

This drug is associated with causing bradycardia and atrial fibrillation.

A

Ivabradine.

84
Q

This drug enhances the production of BMP by directly stimulating sGC independent of NO and enhances sGC sensitivity to endogenous NO.

This increases cGMP production, leading to smooth muscle relaxation and vasodilation.

A

Vericiguat (Verquvo)

85
Q

Vericiguat CI

A

Pregnancy

86
Q

Vericiguat DI

A

PDE5 inhibitors.

87
Q

What drug covered in this section requires a negative pregnancy test prior to initiation?

A

Vericiguat.

88
Q

This drug inhibits sodium/potassium ATPase pump in myocardial cells. –> This leads to a transient increase in intracellular sodium. This leads to an increase in calcium leading to depolarizations and increased contractility.

May also improve baroreflex sensitivity.

A

Digoxin.

89
Q

This drug used to reduce morbidity in HF patients is a major p-glycoprotein substrate, and minor CYP3A4 substrate.

A

Digoxin.

90
Q

Goal Digoxin Serum Trough Concentration

A

0.5-0.9 ng/mL

91
Q

Digoxin ADE

A
  1. Arrythmia
  2. Heart Block
  3. GI/Neurological Side Effects
92
Q

This morbidity reducing drug for HF, is on the BEERS list.

A

Digoxin.

93
Q

What are the risk associated to Digoxin?

A
  1. Cardiac Arrythmias
  2. GI symptoms
  3. Neurological Symptoms
94
Q

When may digoxin be initiated?

A

A patient is already on other GDTM and still symptomatic.

95
Q

What medications should be avoided in HFREF?

A
  1. Non-DHP CCB
  2. Class 1C Antiarrhytmic Drugs and Dronedarone
  3. TZDs (azones)
  4. DPP-4s (gliptins)
  5. NSAIDs.

CRT (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions